MEOX2
Basic information
Region (hg38): 7:15611212-15686683
Previous symbols: [ "GAX" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (48 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MEOX2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005924.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 48 | 48 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 48 | 0 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MEOX2 | protein_coding | protein_coding | ENST00000262041 | 3 | 75601 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124927 | 5 | 523 | 125455 | 0.00211 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.218 | 180 | 172 | 1.05 | 0.00000826 | 1983 |
| Missense in Polyphen | 55 | 73.996 | 0.74328 | 880 | ||
| Synonymous | -1.72 | 90 | 71.5 | 1.26 | 0.00000368 | 588 |
| Loss of Function | 2.99 | 1 | 12.3 | 0.0812 | 6.10e-7 | 128 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00343 | 0.00229 |
| Ashkenazi Jewish | 0.000413 | 0.000199 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00551 | 0.00241 |
| European (Non-Finnish) | 0.00780 | 0.00351 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00192 | 0.000916 |
| Other | 0.00382 | 0.00180 |
dbNSFP
Source:
- Function
- FUNCTION: Mesodermal transcription factor that plays a key role in somitogenesis and is required for sclerotome development (By similarity). Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation. While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner (PubMed:22206000). May have a regulatory role when quiescent vascular smooth muscle cells reenter the cell cycle. {ECO:0000250|UniProtKB:P32443, ECO:0000269|PubMed:22206000}.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.177
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.741
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- angiogenesis;somite specification;multicellular organism development;skeletal muscle tissue development;blood circulation;positive regulation of transcription by RNA polymerase II;roof of mouth development;limb development;somite development;negative regulation of cell migration involved in sprouting angiogenesis
- Cellular component
- nucleus;cytoplasm;nuclear speck
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;sequence-specific DNA binding